These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 22624467)
21. Co-administration of certain DNA vaccine combinations expressing different H5N1 influenza virus antigens can be beneficial or detrimental to immune protection. Patel A; Gray M; Li Y; Kobasa D; Yao X; Kobinger GP Vaccine; 2012 Jan; 30(3):626-36. PubMed ID: 22119588 [TBL] [Abstract][Full Text] [Related]
26. Fabrication of influenza virus-like particles using M2 fusion proteins for imaging single viruses and designing vaccines. Wei HJ; Chang W; Lin SC; Liu WC; Chang DK; Chong P; Wu SC Vaccine; 2011 Sep; 29(41):7163-72. PubMed ID: 21651946 [TBL] [Abstract][Full Text] [Related]
27. Universal type/subtype-specific antibodies for quantitative analyses of neuraminidase in trivalent influenza vaccines. Xu K; Li C; Gravel C; Jiang Z; Jaentschke B; Van Domselaar G; Li X; Wang J Sci Rep; 2018 Jan; 8(1):1067. PubMed ID: 29348625 [TBL] [Abstract][Full Text] [Related]
28. Conserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine development. Staneková Z; Varečková E Virol J; 2010 Nov; 7():351. PubMed ID: 21118546 [TBL] [Abstract][Full Text] [Related]
29. Recognition of the PB1, neuraminidase, and matrix proteins of influenza virus A/NT/60/68 by cytotoxic T lymphocytes. Reay PA; Jones IM; Gotch FM; McMichael AJ; Brownlee GG Virology; 1989 Jun; 170(2):477-85. PubMed ID: 2658303 [TBL] [Abstract][Full Text] [Related]
30. Infectious diseases. WHO ramps up bird flu vaccine efforts. Normile D Science; 2004 Jan; 303(5658):609. PubMed ID: 14752135 [No Abstract] [Full Text] [Related]
31. Enhanced Influenza VLP vaccines comprising matrix-2 ectodomain and nucleoprotein epitopes protects mice from lethal challenge. Gao X; Wang W; Li Y; Zhang S; Duan Y; Xing L; Zhao Z; Zhang P; Li Z; Li R; Wang X; Yang P Antiviral Res; 2013 Apr; 98(1):4-11. PubMed ID: 23416215 [TBL] [Abstract][Full Text] [Related]
32. Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments. Schotsaert M; De Filette M; Fiers W; Saelens X Expert Rev Vaccines; 2009 Apr; 8(4):499-508. PubMed ID: 19348565 [TBL] [Abstract][Full Text] [Related]
33. Examination of influenza specific T cell responses after influenza virus challenge in individuals vaccinated with MVA-NP+M1 vaccine. Powell TJ; Peng Y; Berthoud TK; Blais ME; Lillie PJ; Hill AV; Rowland-Jones SL; McMichael AJ; Gilbert SC; Dong T PLoS One; 2013; 8(5):e62778. PubMed ID: 23658773 [TBL] [Abstract][Full Text] [Related]
34. A lipopeptide based on the M2 and HA proteins of influenza A viruses induces protective antibody. Pejoski D; Zeng W; Rockman S; Brown LE; Jackson DC Immunol Cell Biol; 2010 Jul; 88(5):605-11. PubMed ID: 20177411 [TBL] [Abstract][Full Text] [Related]
35. Preclinical efficacy of a prototype DNA vaccine: enhanced protection against antigenic drift in influenza virus. Donnelly JJ; Friedman A; Martinez D; Montgomery DL; Shiver JW; Motzel SL; Ulmer JB; Liu MA Nat Med; 1995 Jun; 1(6):583-7. PubMed ID: 7585127 [TBL] [Abstract][Full Text] [Related]
36. Comparison of the ability of viral protein-expressing plasmid DNAs to protect against influenza. Chen Z; Sahashi Y; Matsuo K; Asanuma H; Takahashi H; Iwasaki T; Suzuki Y; Aizawa C; Kurata T; Tamura S Vaccine; 1998 Oct; 16(16):1544-9. PubMed ID: 9711802 [TBL] [Abstract][Full Text] [Related]
37. Pandemic H1N1 influenza virus-like particles are immunogenic and provide protective immunity to pigs. Pyo HM; Masic A; Woldeab N; Embury-Hyatt C; Lin L; Shin YK; Song JY; Babiuk S; Zhou Y Vaccine; 2012 Feb; 30(7):1297-304. PubMed ID: 22207090 [TBL] [Abstract][Full Text] [Related]
38. Engineered Nanoparticle Applications for Recombinant Influenza Vaccines. Sia ZR; Miller MS; Lovell JF Mol Pharm; 2021 Feb; 18(2):576-592. PubMed ID: 32787280 [TBL] [Abstract][Full Text] [Related]
39. M2e-based universal influenza vaccines: a historical overview and new approaches to development. Mezhenskaya D; Isakova-Sivak I; Rudenko L J Biomed Sci; 2019 Oct; 26(1):76. PubMed ID: 31629405 [TBL] [Abstract][Full Text] [Related]